SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-07
👔
Dianthus Therapeutics, Inc. /DE/
@DNTH_InsiderForm 4 Filing: Garcia Marino Sells $19.3M of $DNTH
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
Dianthus Therapeutics, Inc. /DE/
Ticker: $DNTH
Transaction Value
$19.3M
Price/Share: $58.27
transaction date
2026-08-07
Shares: 332,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Garcia Marino, holds the title of CEO AND PRESIDENT at Dianthus Therapeutics, Inc. /DE/.
On 2026-08-07, the insider transacted 332,000 shares.The shares were transacted at a weighted average price of $58.27 per share, resulting in a total market-relevant value of $19.3M.
Executive Summary Summary
Garcia Marino (CEO AND PRESIDENT) sold $19.3M of $DNTH
Post-Transaction Position: 87,102 shares
SEC Accession No: 0001669866-26-000010 (CIK: 1669866)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.